Did you know that…
- Every employer with at least one employee is required to have an in-house safety officer.
- If there are fewer than 20 employees, the employer may serve as the safety and health advisor. Otherwise, the employer must appoint a staff member who does not hold a managerial position to serve as the safety and health advisor.
- This person must have a basic understanding of workplace safety and well-being. This can be demonstrated by completing a Level 3 safety advisor course.
- The prevention advisor must also undergo regular continuing education (at least once a year) to stay up to date on developments in the field.
Duties of the Prevention Advisor
The Workplace Well-Being Act (Codex Welzijn Op Het Werk) provides a legal framework for the prevention advisor. The Workplace Well-Being Act outlines the working conditions that must be respected. According to the Workplace Well-Being Act, well-being revolves around:
- Workplace safety
- Protection of employees’ health
- Ergonomics
- Occupational hygiene
- Improvement of the workplace environment
- Psychosocial Aspects in and Around the Workplace
The prevention advisor assists the employer in implementing measures related to well-being and serves in an advisory capacity. The prevention advisor’s duties are focused on identifying risks and preventing them through preventive measures and procedures:
- Risk analysis: identifying hazards, investigating workplace accidents …
- Advice: advising on workplace organization and environmental factors, work equipment, hygiene…
- Administration: drafting annual reports, developing a comprehensive prevention plan, drawing up procedures…
A Word from Our Safety Advisor
Given our company’s strong growth over the past year, we have reached the milestone of 20 salaried employees. Effective immediately, our consultant Dorien will assume the role of safety advisor.
“When I started at Farma Consulting & Partners, I had already earned my Level 3 safety advisor certification. Upon reaching the 20-employee mark, I was asked if I’d be interested in taking on the role of in-house safety and health advisor. I didn’t hesitate for a moment, and I’m eager to become the driving force behind safety and health. I’m happy that, through my role, I can contribute to greater well-being, safety, and happiness in the workplace for all my colleagues!”
Your partner in quality, safety, and compliance
The life sciences sector requires specialized knowledge and reliable guidance. Thanks to our extensive expertise, we help organizations comply with laws and regulations, ensure quality, and continue to innovate with confidence.
Related Services
Related Articles
10 Jul 2026
Project Management
In the complex and highly regulated world of the pharmaceutical industry, project management plays a pivotal role to bring life-saving medications and treatments to the market. From drug discovery to clinical trials and regulatory approval, effective project management is essential for managing timelines, resources, and compliance. Let’s dive in some practical tips and tricks specifically for navigating the complexities of project management in the pharmaceutical sector.
10 Jul 2026
Potential Pitfalls in an MES Project
Just as every project has its pitfalls, the same is true for a Manufacturing Execution System (MES) implementation project. Implementing electronic batch records is no easy task. That’s why, in the blog below, we’ll share a few pitfalls so you can prepare for a successful implementation within your company.
10 Jul 2026
Streamlining Post-Marketing Surveillance with IMDRF Coding
Since the implementation of the Medical Device Regulation (MDR) in Europe, companies have had to maintain and execute a post-marketing surveillance (PMS) procedure. This systematic process involves collecting and analysing data on the performance and safety of medical devices after they have been released to the market. The primary goal is to help manufacturers identify and address potential issues that may arise during actual use, monitor the market for known risks, and identify new risks.
10 Jul 2026
ISO 9001:2015 in Life Sciences Industry
In the life sciences industry, maintaining high quality standards is critical not only to the success and sustainability of organizations but also to patient safety and compliance. ISO 9001:2015, part of the ISO 9000 family, provides a robust framework for quality management systems (QMS) that can be used in organizations in the life sciences, including pharmaceutical, natural technology, including medical devices. This article examines the key features of ISO 9001:2015, its benefits, implementation methods, potential pitfalls, and impact in the life sciences.
10 Jul 2026
The Role of a CQV Expert in the Cold Chain Division of a Pharmaceutical Company
In the pharmaceutical industry, product quality is of vital importance. This is particularly true for medicinal products that are sensitive to temperature fluctuations, such as vaccines, biologics, and certain medications that must be stored and transported in a controlled environment. Within this process, the CQV (Commissioning, Qualification, and Validation) expert plays a crucial role, especially within the cold chain division, which is responsible for monitoring product quality during the transport and storage of these temperature-sensitive products. This blog outlines the various aspects a CQV expert must consider in this context.
10 Jul 2026
Radiopharmaceutical & Selective Internal Radiation Treatments: Overcoming Challenges and Embracing Future Opportunities
Radiopharmaceutical and selective internal radiation treatments have emerged as a transformative force in the pharmaceutical industry, offering precision, personalized therapies for patients with conditions such as cancer and other serious diseases.
10 Jul 2026
Implementation of the European Clinical Trial Regulation (EU-CTR)
By the end of this month (31st of January 2025), the final deadline is reached in the transition period for the implementation of the European Clinical Trial Regulation (EU-CTR). What is it and what is the difference with the previous European Clinical Trial Directive (EU-CTD)?